LTFS
ATHE

Ladenburg Thalmann Financial Services’s Alterity Therapeutics ATHE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20
Closed – – 4838
2016
Q4 		$0 Hold
20
– – ﹤0.01% 4833
2016
Q3 		$1K Buy
+20
New +$997 ﹤0.01% 4588
2015
Q4 		– Sell
-50
Closed -$3K – 4669
2015
Q3 		$3K Hold
50
– – ﹤0.01% 4118
2015
Q2 		$4K Buy
+50
New +$3.76K ﹤0.01% 4113

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ATHE Position: Q1 2017 in Review

Ladenburg Thalmann Financial Services sold out of Alterity Therapeutics (ATHE) in Q1 2017, closing a stake of 20 shares.

Ladenburg Thalmann Financial Services first reported a position in ATHE in Q2 2015 and held it in 4 quarters. The position peaked at $4K in Q2 2015. 11 funds tracked by Wall St. Rank hold ATHE as of Q1 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Alterity Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 20 Alterity Therapeutics shares in Q1 2017.
  • Ladenburg Thalmann Financial Services first reported a position in Alterity Therapeutics in Q2 2015 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's Alterity Therapeutics position peaked at $4K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2017, filed 15 May 2017.